Autosomal dominant optic atrophy

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Sep 2025Safety of Single and Repeat Dose of PYC-001 Eye Injections in People With Autosomal Dominant Optic Atrophy

PYC Therapeutics — PHASE1, PHASE2

TrialRECRUITING
Oct 2024SAD of IVT PYC-001 in OPA1 Mutation-Associated Autosomal Dominant Optic Atrophy (Sundew)

PYC Therapeutics — PHASE1

TrialACTIVE NOT RECRUITING
Jan 2024Tolerance and Efficacy Nicotinamide (vitamin B3) in Dominant Optic Atrophy OPA1

University Hospital, Angers — PHASE2, PHASE3

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Autosomal dominant optic atrophy.
Check the disease page for updates →

Clinical Trial Landscape

2 active trials
1Phase 1
1PHASE1, PHASE2
2Total recruiting
Search clinical trials for Autosomal dominant optic atrophy

Recent News & Research

No recent news articles indexed yet for Autosomal dominant optic atrophy.
Search PubMed for Autosomal dominant optic atrophy

Browse all Autosomal dominant optic atrophy news →

Specialist Network

No specialists currently listed for Autosomal dominant optic atrophy.

View all Autosomal dominant optic atrophy specialists →

Quick Actions